Olaf Schneider is the CEO of Cerascreenbased in Hamburg, Germany. Cerascreen offers an Epigenetic Age Test to Consumers. This test was developed in conjunction with Dr Sheraz Gul, Head of Drug Discovery at the Fraunhofer Institute using Illumina technology. The test estimates biological age and allows a person to take a broad look at their overall health. The difference between biological age and chronological age gives an indication whether someone should take extra steps to improve their health to decrease their biological age.
Subscribe to the Illumina video channel http://www.youtube.com/subscription_center?add_user=IlluminaInc
A global genomics leader, Illumina provides comprehensive next-generation sequencing solutions to the research, clinical, and applied markets. Illumina technology is responsible for generating more than 90% of the world’s sequencing data.* Through collaborative innovation, Illumina is fueling groundbreaking advancements in oncology, reproductive health, genetic disease, microbiology, agriculture, forensic science, and beyond.
*Data calculations on file. Illumina, Inc., 2015.
View customer spotlight videos
View Illumina webinars
View Illumina product videos
View Illumina support videos